Entity Common Stock, Shares Outstanding of Actinium Pharmaceuticals, Inc. from 08 Aug 2011 to 14 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Actinium Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 08 Aug 2011 to 14 Nov 2025.
  • Actinium Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 14 Nov 2025 was 31,195,891, unchanged year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Actinium Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 31,195,891 0 0% 14 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 31,195,891 +41,515 +0.13% 08 Aug 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 31,195,891 +1,799,480 +6.1% 28 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 31,195,891 +3,782,450 +14% 14 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 31,154,376 +4,156,789 +15% 02 Aug 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 29,396,411 +3,667,041 +14% 27 Mar 2024 10-K 29 Mar 2024 2023 FY
Q3 2023 27,413,441 +1,930,135 +7.6% 01 Nov 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 26,997,587 +1,812,933 +7.2% 14 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 25,729,370 +3,585,396 +16% 31 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 25,483,306 +3,452,468 +16% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 25,184,654 +3,853,340 +18% 12 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 22,143,974 +2,898,336 +15% 25 Mar 2022 10-K 25 Mar 2022 2021 FY
Q3 2021 22,030,838 +8,444,313 +62% 12 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 21,331,314 -373,823,412 -95% 28 Jul 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 19,245,638 -284,098,061 -94% 31 Mar 2021 10-K 31 Mar 2021 2020 FY
Q3 2020 13,586,525 -151,114,642 -92% 23 Oct 2020 10-Q 23 Oct 2020 2020 Q3
Q2 2020 395,154,726 +232,729,126 +143% 29 Jun 2020 10-Q 29 Jun 2020 2020 Q1
Q1 2020 303,343,699 +184,207,663 +155% 07 May 2020 10-K 08 May 2020 2019 FY
Q3 2019 164,701,167 +49,003,123 +42% 12 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 162,425,600 +51,962,147 +47% 09 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 119,136,036 +8,937,376 +8.1% 15 Mar 2019 10-K 15 Mar 2019 2018 FY
Q3 2018 115,698,044 +35,672,405 +45% 09 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 110,463,453 +30,442,880 +38% 09 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 110,198,660 +54,390,918 +97% 16 Mar 2018 10-K 16 Mar 2018 2017 FY
Q3 2017 80,025,639 +24,278,531 +44% 03 Nov 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 80,020,573 +32,303,427 +68% 04 Aug 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 55,807,742 +11,416,645 +26% 16 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 55,747,108 +13,729,609 +33% 28 Oct 2016 10-Q 28 Oct 2016 2016 Q3
Q2 2016 47,717,146 +7,081,292 +17% 28 Jul 2016 10-Q 29 Jul 2016 2016 Q2
Q1 2016 44,391,097 +8,909,021 +25% 10 Mar 2016 10-K 11 Mar 2016 2015 FY
Q3 2015 42,017,499 +12,011,992 +40% 29 Oct 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 40,635,854 +12,488,790 +44% 06 Aug 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 35,482,076 +10,157,098 +40% 16 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 30,005,507 +6,348,925 +27% 30 Oct 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 28,147,064 +11,849,987 +73% 11 Aug 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 25,324,978 +13,271,573 +110% 26 Feb 2014 10-K 28 Feb 2014 2013 FY
Q3 2013 23,656,582 +12,501,574 +112% 12 Nov 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 16,297,077 +5,142,069 +46% 12 Aug 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 12,053,405 +898,397 +8.1% 26 Mar 2013 10-K 29 Mar 2013 2012 FY
Q3 2012 11,155,008 0 0% 30 Oct 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 11,155,008 0 0% 06 Aug 2012 10-Q/A 29 Aug 2012 2012 Q2
Q1 2012 11,155,008 17 Apr 2012 10-Q 23 Apr 2012 2012 Q1
Q3 2011 11,155,008 04 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 11,155,008 08 Aug 2011 10-Q 12 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.